Ahmed Idbaih, et al.
ASCO 2017, June 2017 – Download the abstract
Abstract
TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma
Par Lucie Larguier|2019-07-02T10:40:35+02:00juin 5th, 2017|Publication, TG6002|Commentaires fermés sur TG6002: A novel oncolytic and vectorized gene pro-drug therapy approach to treat glioblastoma
À propos de l'auteur : Lucie Larguier
Articles similaires
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity